Validation of olfactory deficit as a biomarker of Alzheimer disease
نویسندگان
چکیده
منابع مشابه
Validation of olfactory deficit as a biomarker of Alzheimer disease.
BACKGROUND We evaluated smell identification as a biomarker for Alzheimer disease (AD) by assessing its utility in differentiating normal aging from an amnestic disorder and determining its predictive value for conversion from amnestic mild cognitive impairment (aMCI) to AD. METHODS Cross-sectional study (AD = 262, aMCI = 110, controls = 194) measuring smell identification (University of Penn...
متن کاملBiomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
OBJECTIVE To compare cued recall measures with other memory and nonmemory tests regarding their association with a biomarker profile indicative of Alzheimer disease (AD) in CSF among patients with mild cognitive impairment (MCI). METHODS Data were obtained by the German Dementia Competence Network. A total of 185 memory clinic patients fulfilling broad criteria for MCI (1 SD deficit in memory...
متن کاملAs a Biomarker for Alzheimer Disease
The search is ongoing for a reliable serum biomarker for AD. The level of iron is elevated in the brain of Alzheimer’s disease (AD) patients. Our studies have demonstrated that the level of the iron transport protein, p97, is increased in the serum of AD patients but not in various control groups. These results have recently been confirmed by another laboratory who extended our findings by demo...
متن کاملRole of microRNA as a biomarker in Alzheimer’s disease
Introduction: MicroRNAs are small, non-coding, and protected RNA molecules that regulate gene expression after transcription by mRNA degradation or inhibition of protein synthesis. The function of these molecules is critical to many cellular processes, including growth, development, differentiation, homeostasis, apoptosis, aging, stress resistance. In addition, some diseases including cancer, a...
متن کاملOlfactory deficit and hippocampal volume loss for early diagnosis of Alzheimer disease: a pilot study.
BACKGROUND The aim of this pilot study was to verify the role of olfactory test and volumetric magnetic resonance imaging measure of hippocampus to predict conversion from mild cognitive impairment to Alzheimer disease (AD). MATERIALS AND METHODS Eighteen patients with amnesic mild cognitive impairment, broadly defined, were followed at 12 months. Hypothesized baseline predictors for follow-u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology: Clinical Practice
سال: 2016
ISSN: 2163-0402,2163-0933
DOI: 10.1212/cpj.0000000000000293